Sutent for sale Sutent for sale in India Sunitinib for sale

If the WeChat consultation hotline cannot be reached, please add WeChat or the common name: Sunitinib Malate Capsules. Our company promises: Integrity-based, genuine products at reasonable prices, selling conscientious medicines, cash on delivery, Generic name: Sunitinib Malate Capsules Molecule Structural name: Sunitinib malate English name: Specifications: .× capsules/box Usage: capsules per day, taken once a day, need to stop taking the drug after a few weeks and continue to take it after a week of observation Duration of treatment: Weeks/course of treatment Indications: IMA Gastrointestinal stromal tumors and advanced renal cell carcinoma that have failed or cannot be tolerated by Tinib. Manufacturer: Pfizer Indications: In addition to gastrointestinal stromal tumors, it can inhibit advanced renal cell carcinoma and is now clinically proven to treat non-small cell lung cancer. Cell lung cancer, treatment of hepatocellular carcinoma. [Sutent Indications] Gastrointestinal stromal tumors that have failed or are intolerant to imatinib mesylate treatment. .Inoperable advanced renal cell carcinoma (R). Sunitinib (Sutent) - a new drug for kidney cancer, gastrointestinal stromal tumor, non-small cell lung cancer, and liver cancer. Indications Multi-targeted treatment of tumors Sunitinib (b,) is a new multi-targeted oral drug for the treatment of tumors. Sunitinib is primarily being developed for the treatment of gastrointestinal stromal tumors and metastatic renal cell carcinoma that are unresponsive or intolerant to standard therapies. Sunitinib selectively targets receptors on certain proteins, which are thought to act like a molecular switch in tumor growth. The above indications of sunitinibb/> [Sutent usage and dosage] The recommended dose for the treatment of gastrointestinal stromal tumors and advanced renal cell carcinoma is once daily, oral administration week, and drug withdrawal week (/dosing schedule) . It can be taken with or without food. [Precautions for Sutent] If clinical manifestations of congestive heart failure occur, it is recommended to discontinue the drug. Patients with no clinical evidence of congestive heart failure but an ejection fraction < and an ejection fraction below baseline should also be discontinued and/or dose reduced. Sutent prolongs the interval in a dose-dependent manner. It should be used with caution in patients with a known history of interval prolongation, patients taking antiarrhythmic drugs, or patients with corresponding underlying heart disease, bradycardia, and electrolyte imbalance. If severe hypertension occurs during use, use should be suspended until the hypertension is controlled. Women of childbearing potential should use contraception while receiving Sutent. Breastfeeding women receiving Sutent should weigh the decision as to whether to discontinue breastfeeding or discontinue treatment. No differences in safety or effectiveness were found in younger versus older patients. [Sutent Properties] Capsules, the contents are ** to orange particles. [Sutent Validity Period] Months [Sutent Approval Number] Registration Certificate Number 3 [Sutent Manufacturer] .R..